SCHEMBL8304743

SCHEMBL8304743

CCNc1ncccc1C(=O)Nc1c(C)ccnc1Cl

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.46
MEN1 O00255 5/20 0.46
MAPT P10636 4/20 0.46
KDM4E B2RXH2 3/20 0.46
HTT P42858 2/20 0.46
LMNA P02545 1/20 0.46
GLA P06280 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
KDR P35968 6/20 0.45
ALDH1A1 P00352 5/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
GAA P10253 2/20 0.42
MAPK14 Q16539 1/20 0.42
NPC1 O15118 2/20 0.41
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5743583 0.85 KDR (0.43) KMT2AMEN1MAPTKDM4EHTT
SCHEMBL29693646 0.85 NPC1 (0.55) KMT2AMEN1MAPTKDM4EHTT
SCHEMBL29948741 0.85 NPC1 (0.55) KMT2AMEN1MAPTKDM4EHTT
SCHEMBL29948971 0.85 NPC1 (0.55) KMT2AMEN1MAPTKDM4EHTT
SCHEMBL1923392 0.85 NPC1 (0.55) KMT2AMEN1MAPTKDM4EHTT
SCHEMBL14439914 0.82 KMT2A (0.45) KMT2AMEN1MAPTKDM4EHTT
SCHEMBL30434880 0.81 LCK (0.43) KMT2AMEN1MAPTHTTLMNA
SCHEMBL30434727 0.81 LCK (0.43) KMT2AMEN1MAPTHTTLMNA
SCHEMBL1923555 0.81 LCK (0.43) KMT2AMEN1MAPTHTTLMNA
SCHEMBL14031772 0.80 KMT2A (0.42) KMT2AMEN1MAPTHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070190523-A1 Method and compositions for identifying anti-hiv therapeutic compounds GILEAD SCIENCES, INC. 2007-08-16 US disclosed
EP-0429987-B1 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1999-03-17 EP disclosed
US-5620974-A ENZYME INHIBITOR, TREATS ACQUIRED IMMUNE DEFICIENCY SYNDROME(AIDS) BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1997-04-15 US disclosed
US-5366972-A 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1994-11-22 US disclosed
EP-0429987-A2 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1991-06-05 EP disclosed